Steve Potts, PhD, MBA, CEO and Co-Founder, Stealth Cancer Biotech episode artwork

EPISODE · Oct 6, 2025 · 41 MIN

Steve Potts, PhD, MBA, CEO and Co-Founder, Stealth Cancer Biotech

from Perspectives by the Leerink Center for Pharmacoeconomics · host The Leerink Center for Pharmacoeconomics

Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics, interviews Steve Potts, PhD, MBA, CEO and Co-Founder, Stealth Cancer Biotech, to discuss the impact of the Inflation Reduction Act on cancer drug development and a middle ground between a market-based approach and a government-based approach to drug pricing.

Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics, interviews Steve Potts, PhD, MBA, CEO and Co-Founder, Stealth Cancer Biotech, to discuss the impact of the Inflation Reduction Act on cancer drug development and a middle ground between a market-based approach and a government-based approach to drug pricing.

NOW PLAYING

Steve Potts, PhD, MBA, CEO and Co-Founder, Stealth Cancer Biotech

0:00 41:43

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Perspectives by the Leerink Center for Pharmacoeconomics?

This episode is 41 minutes long.

When was this Perspectives by the Leerink Center for Pharmacoeconomics episode published?

This episode was published on October 6, 2025.

What is this episode about?

Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics, interviews Steve Potts, PhD, MBA, CEO and Co-Founder, Stealth Cancer Biotech, to discuss the impact of the Inflation Reduction Act on cancer drug development and a middle ground...

Can I download this Perspectives by the Leerink Center for Pharmacoeconomics episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!